FINWIRES · TerminalLIVE
FINWIRES

Sun Life Financial Reaches Settlement in Principle to Resolve MetLife Class Action; AM Best Affirms Credit Ratings

作者

-- Sun Life Financial (SLF.TO) Thursday after trade said it has reached a settlement in principle to resolve a class action relating to individual life insurance policies sold and issued by MetLife in the 1980s and 1990s, which Sun Life inherited through acquisitions.

This matter does not involve any policies or products sold by Sun Life, the company said.

If approved, Sun Life would provide up to $213.5 million settlement value to eligible policyholders, which is expected to result in a charge to first quarter 2026 reported net income of approximately $145 million.

The proceedings relate to the interpretation of policy language in the policies, which are subject to an indemnity from MetLife. Sun Life will seek full recourse from MetLife pursuant to the indemnity, if the settlement is approved, it confirmed.

Separately, AM Best affirmed the financial strength rating (FSR) of A+ (Superior) and the long-term issuer credit ratings (Long-Term ICR) of "aa" (Superior) of Sun Life Assurance Company of Canada and Sun Life and Health Insurance Company (U.S.), core insurance subsidiaries of Sun Life Financial. AM Best also affirmed the Long-Term ICR of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of SLF. The outlook of these ratings is stable.

The ratings reflect Sun Life Group's balance sheet strength, which AM Best assesses as strongest, strong operating performance, favorable business profile and very strong enterprise risk management.

Sun Life Financial shares are unchanged at US$72.08 in U.S. after-hours trade. It closed up $1.30, to $97.87 on the Toronto Stock Exchange.

相关文章

Asia

盛和资源第一季度利润飙升94%,营收增长13%

据盛和资源(SHA:600392)周四在上海证券交易所发布的公告显示,该公司第一季度归属于股东的净利润同比增长94%,从去年同期的1.683亿元人民币增至3.273亿元人民币。 每股收益同比增长0.1867元人民币,高于去年同期的0.0960元人民币。 这家中国稀土矿商的营业收入同比增长13%,从去年同期的29.9亿元人民币增至33.8亿元人民币。

$SHA:600392
Research

研究报告提醒:CFRA重申对希尔顿全球控股公司股票的卖出评级

独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将12个月目标价上调9美元至293美元,相当于2026年每股收益预期(维持不变)的32倍,与该股五年平均远期市盈率一致。我们将2026年每股收益预期从8.88美元上调至9.16美元,并将2027年每股收益预期从10.20美元下调至10.03美元。鉴于第一季度业绩超出预期并上调了业绩指引,我们维持2星(卖出)评级。美国每间可供出租客房收入(RevPAR)的增长范围从主要来自豪华和高端市场扩展到更多中端市场,管理层认为这得益于中低收入消费者的回归。然而,我们注意到第一季度业绩也包括平均房价(ADR)增速放缓,尤其是在历来贡献显著利润的豪华酒店。 HLT第二季度EBITDA预期为10.15亿至10.35亿美元,低于市场普遍预期的10.81亿美元,这表明奢侈品定价权的减弱速度超过了中端市场销量增长所能弥补的幅度。尽管需求增长趋势向好,但我们认为奢侈品市场利好因素的放缓限制了其在当前估值水平下的上涨空间。

$HLT
Research

研究快讯:CFRA维持对环球健康服务公司股票的买入评级

独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将UHS的12个月目标价从243美元下调至200美元,相当于我们2026年每股收益预期的8.7倍,低于同业平均水平,也低于UHS五年历史平均预期市盈率11.9倍。我们将2026年每股收益预期从23.39美元下调至22.95美元,并将2027年预期从25.67美元下调至25.48美元。第一季度住院量与上一季度持平,受到冬季恶劣天气和流感/呼吸道疾病流行程度较轻等季节性不利因素的影响。 近期《平价医疗法案》(ACA)电子支付税收抵免(EPTC)的到期也带来了挑战,UHS预计,与2025年第一季度相比,ACA调整后的入院人数将下降近5%。UHS维持了此前的预测,即全年ACA交易所的交易量将下降25%-30%,这约占2025年急性护理业务调整后入院人数的6%,以及急性护理业务收入的不到5%。UHS预计,这些因素将导致其2026年税前利润减少7500万美元,与此前的预期一致。

$UHS